Tomomitsu Miyagaki

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions

Ayumi Yoshizaki, Tomomitsu Miyagaki, David J. DiLillo et al. · Nature · 2012 · 629 citations

Life Sciences, Cell Biology, Immunology +12

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Julia Scarisbrick, H. Miles Prince, Maarten H. Vermeer et al. · Journal of Clinical Oncology · 2015 · 421 citations · Full text

Medicine, Dermatology, Oncology +17

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

Pietro Quaglino, Milena Maule, H. Miles Prince et al. · Annals of Oncology · 2017 · 136 citations · Full text

Medicine, Dermatology, Oncology +12

Association of the numbers of CD163+ cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma

Makoto Sugaya, Tomomitsu Miyagaki, Hanako Ohmatsu et al. · Journal of Dermatological Science · 2012 · 110 citations

Medicine, Dermatology, Immunology +15